Loading provider…
Loading provider…
Facial Plastic Surgery Physician in New Hyde Park, NY
NPI: 1134109879Primary Practice Location
GOOD SAMARITAN HOSPITAL MEDICAL CENTER
1000 Montauk Hwy, West Islip, NY
Primary Employer
ENT and Allergy Associates LLP
entandallergy.com
HQ Phone
Get MD Moshe's Phone Numberphone_androidMobile
Get MD Moshe's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1995 - 2026
NJ State Medical License
2012 - 2025
LA State Medical License
1998 - 2000

American Board of Otolaryngology - Head and Neck Surgery
Otolaryngology
Zucker School of Medicine at Hofstra/Northwell
Residency • Otolaryngology - Head and Neck Surgery
1993 - 1998
Internship • Transitional Year
1993 - 1994
LSU Health Sciences Center New Orleans - School of Medicine
medschool.lsuhsc.edu
Until 1999
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 610 | 827 |
| 2 | 31231Diagnostic examination of nasal passages using an endoscope | 436 | 575 |
| 3 | 99203New patient outpatient visit, total time 30-44 minutes | 348 | 348 |
| 4 | 69210Removal of impact ear wax, one ear | 278 | 329 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 247 | 286 |
In-office treatment of nasal valve obstruction using a novel, bipolar radiofrequency device.
Authors: Ofer Jacobowitz, Mark Driver
Journal: Laryngoscope Investig Otolaryngol
Publication Date: 2019-02-04
Quality-of-life impact after in-office treatment of nasal valve obstruction with a radiofrequency device: 2-year results from a multicenter, prospective clinical trial.
Authors: Ofer Jacobowitz, Mark Driver
Publication Date: 2020-03-04
Lead Sponsor: Lyra Therapeutics
Intervention / Treatment: DRUG: Sham procedure control, OTHER: Background Therapy, DRUG: LYR-210
Lead Sponsor: Lyra Therapeutics
Intervention / Treatment: DRUG: Bilateral sham procedure control (Part 2), DRUG: LYR-220 Design 1 (Part 1 only), DRUG: LYR-220 Design 2 (Part 1 and Part 2)
Lead Sponsor: Aerin Medical
Intervention / Treatment: DEVICE: Vivaer Stylus